Literature DB >> 19328977

Chronic liver allograft dysfunction.

M Desai1, J Neuberger.   

Abstract

Approximately 90% of liver transplant patients are alive after 1 year and 75% after 5 years with the majority leading full and near-normal lives. However, although early mortality rates after transplantation have fallen dramatically over the last 2 decades, the rates of late graft loss and patient death have remained constant. Thus, understanding of the causes of graft and patient failure is essential to improve long-term outcomes. In the early days after liver transplantation, ischemia and reperfusion injuries predominate, with acute cellular rejection relatively common in first 3 months. Thereafter, the causes of graft dysfunction are variable with disease recurrence as a major cause of graft loss. In this review, we discuss causes of graft dysfunction after 6 months.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19328977     DOI: 10.1016/j.transproceed.2009.01.038

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  13 in total

1.  Chronic bile duct hyperplasia is a chronic graft dysfunction following liver transplantation.

Authors:  Jian-Wen Jiang; Zhi-Gang Ren; Guang-Ying Cui; Zhao Zhang; Hai-Yang Xie; Lin Zhou
Journal:  World J Gastroenterol       Date:  2012-03-14       Impact factor: 5.742

2.  Flow cessation triggers endothelial dysfunction during organ cold storage conditions: strategies for pharmacologic intervention.

Authors:  Jorge Gracia-Sancho; Guadalupe Villarreal; Yuzhi Zhang; Jessica X Yu; Yao Liu; Stefan G Tullius; Guillermo García-Cardeña
Journal:  Transplantation       Date:  2010-07-27       Impact factor: 4.939

Review 3.  Long term outcomes after pediatric liver transplantation.

Authors:  Nada A Yazigi
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2013-12-31

Review 4.  Post-operative imaging in liver transplantation: state-of-the-art and future perspectives.

Authors:  Rossano Girometti; Giuseppe Como; Massimo Bazzocchi; Chiara Zuiani
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

5.  Histological and Clinicopathological Evaluation of Liver Allograft Biopsy: An Initial Experience of Fifty Six Biopsies.

Authors:  K V Kanodia; A V Vanikar; P R Modi; R D Patel; K S Suthar; L K Nigam; H L Trivedi
Journal:  J Clin Diagn Res       Date:  2015-11-01

Review 6.  Magnetic resonance cholangiography in the assessment and management of biliary complications after OLT.

Authors:  Rossano Girometti; Lorenzo Cereser; Massimo Bazzocchi; Chiara Zuiani
Journal:  World J Radiol       Date:  2014-07-28

7.  Sluggish decline in a post-transplant model for end-stage liver disease score is a predictor of mortality in living donor liver transplantation.

Authors:  Won Jung Hwang; Joon Pyo Jeon; Seung Hee Kang; Hyun Sik Chung; Ji Yong Kim; Chul Soo Park
Journal:  Korean J Anesthesiol       Date:  2010-09-20

8.  Improvement of Liver Transplantation Outcome by Heme Oxygenase-1-Transduced Bone Marrow Mesenchymal Stem Cells in Rats.

Authors:  Bin Wu; Hong-Li Song; Yang Yang; Ming-Li Yin; Bo-Ya Zhang; Yi Cao; Chong Dong; Zhong-Yang Shen
Journal:  Stem Cells Int       Date:  2016-01-05       Impact factor: 5.443

9.  Histopathological causes of late liver allograft dysfunction: analysis at a single institution.

Authors:  Eun Shin; Ji Hoon Kim; Eunsil Yu
Journal:  Korean J Pathol       Date:  2013-02-25

10.  De novo autoimmune hepatitis following liver transplantation for primary biliary cirrhosis: an unusual cause of late grafts dysfunction.

Authors:  Rym Ennaifer; Hend Ayadi; Haifa Romdhane; Meriem Cheikh; Hafedh Mestiri; Taher Khalfallah; Najet Bel Hadj
Journal:  Pan Afr Med J       Date:  2015-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.